Similar articles for PMID: 24788545

Year	Number of Results
2007	1
2010	6
2011	11
2012	16
2013	24
2014	11
2015	5
2016	4
2018	2
2019	1
2021	3
2022	1
2024	0

1

Kharazmi M, Hallberg P, Michaëlsson K. Kharazmi M, et al. Ann Rheum Dis. 2014 Aug;73(8):1594. doi: 10.1136/annrheumdis-2013-205080. Epub 2014 Apr 30. Ann Rheum Dis. 2014. PMID: 24788545 No abstract available.

2

Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.

Kharazmi M, Hallberg P, Warfvinge G, Michaëlsson K. Kharazmi M, et al. Rheumatology (Oxford). 2014 Oct;53(10):1911-3. doi: 10.1093/rheumatology/keu286. Epub 2014 Aug 6. Rheumatology (Oxford). 2014. PMID: 25099769 No abstract available.

3

Antiresorptive Therapies for Osteoporosis.

Weinerman S, Usera GL. Weinerman S, et al. Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):555-60. doi: 10.1016/j.coms.2015.07.001. Epub 2015 Sep 26. Oral Maxillofac Surg Clin North Am. 2015. PMID: 26412797 Review.

4

FPIN's clinical inquiries. Risks of bisphosphonate use.

Scott MA, Meadowcraft L, Skolnik D. Scott MA, et al. Am Fam Physician. 2013 Nov 15;88(10):697, 702. Am Fam Physician. 2013. PMID: 24364486 Free article. Review. No abstract available.

5

Identification of Risk Factors for Bisphosphonate-Associated Atypical Femoral Fractures and Osteonecrosis of the Jaw in a Pharmacovigilance Database.

Bejhed RS, Kharazmi M, Hallberg P. Bejhed RS, et al. Ann Pharmacother. 2016 Aug;50(8):616-24. doi: 10.1177/1060028016649368. Epub 2016 May 13. Ann Pharmacother. 2016. PMID: 27179251

6

Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review.

Graves LL, Bukata SV, Aghazadehsanai N, Chang TI, Garrett NR, Friedlander AH. Graves LL, et al. J Oral Maxillofac Surg. 2016 Dec;74(12):2403-2408. doi: 10.1016/j.joms.2016.06.003. Epub 2016 Jun 12. J Oral Maxillofac Surg. 2016. PMID: 27376180 Review.

7

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM. McClung M, et al. Am J Med. 2013 Jan;126(1):13-20. doi: 10.1016/j.amjmed.2012.06.023. Epub 2012 Nov 20. Am J Med. 2013. PMID: 23177553 Review.

8

Atypical femoral fractures and bisphosphonate use.

Girgis CM, Sher D, Seibel MJ. Girgis CM, et al. N Engl J Med. 2010 May 13;362(19):1848-9. doi: 10.1056/NEJMc0910389. N Engl J Med. 2010. PMID: 20463351 No abstract available.

9

Going on a drug holiday?

Bonnick SL. Bonnick SL. J Clin Densitom. 2011 Oct-Dec;14(4):377-83. doi: 10.1016/j.jocd.2011.07.006. J Clin Densitom. 2011. PMID: 22051091 No abstract available.

10

Skeletal complications of bisphosphonate use: what the radiologist should know.

Haworth AE, Webb J. Haworth AE, et al. Br J Radiol. 2012 Oct;85(1018):1333-42. doi: 10.1259/bjr/99102700. Br J Radiol. 2012. PMID: 22972971 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year